pyrazines has been researched along with Bleeding in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (45.45) | 29.6817 |
| 2010's | 4 (36.36) | 24.3611 |
| 2020's | 2 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, F; Hu, Y; Jiang, D; Song, Z; Zhao, R | 1 |
| Lamanna, N; Lipsky, A | 1 |
| Chen, H; Chen, K; Chen, Y; Chu, J; Li, L; Li, Q; Liu, L; Peng, J; Shen, A | 1 |
| Bernlochner, I; Busygina, K; Denzinger, V; Lorenz, R; Siess, W; Weber, C | 1 |
| Alinari, L; Bond, DA; Maddocks, K | 1 |
| Bladé, J; Cibeira, MT; Fernández de Larrea, C; Lloreta, J; Mascaró, JM; Rovira, M; Serra, N; Solé, M; Torras, A | 1 |
| Eby, C | 1 |
| Hirakawa, T; Inokuchi, K; Yokose, N | 1 |
| Wirk, B | 1 |
| Nicholson, NS; Parlow, JJ; Salyers, AK; South, MS; Suleymanov, OD; Szalony, JA; Wood, RS | 1 |
| Howes, JM; Laing, GD; Theakston, RD | 1 |
5 review(s) available for pyrazines and Bleeding
| Article | Year |
|---|---|
Risk of bleeding associated with BTK inhibitor monotherapy: a systematic review and meta-analysis of randomized controlled trials.
Topics: Benzamides; Hemorrhage; Humans; Protein Kinase Inhibitors; Pyrazines; Randomized Controlled Trials as Topic | 2022 |
Managing toxicities of Bruton tyrosine kinase inhibitors.
Topics: Adenine; Agammaglobulinaemia Tyrosine Kinase; Aged; Animals; Arrhythmias, Cardiac; Arthralgia; Benzamides; Diarrhea; Hemorrhage; Humans; Hypertension; Infection Control; Infections; Male; Piperidines; Protein Kinase Inhibitors; Pyrazines | 2020 |
Btk Inhibitors as First Oral Atherothrombosis-Selective Antiplatelet Drugs?
Topics: Adenine; Administration, Oral; Agammaglobulinaemia Tyrosine Kinase; Agammaglobulinemia; Animals; Arteries; B-Lymphocytes; Benzamides; Blood Platelets; Cell Differentiation; Genetic Diseases, X-Linked; Hemorrhage; Humans; Imidazoles; Mice; Piperidines; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Protein Kinase Inhibitors; Pyrazines; Pyrazoles; Pyrimidines; Signal Transduction; Thrombosis | 2019 |
Bruton tyrosine kinase inhibitors for the treatment of mantle cell lymphoma: review of current evidence and future directions.
Topics: Adenine; Agammaglobulinaemia Tyrosine Kinase; Antigens, CD20; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Cardiovascular Diseases; Clinical Trials as Topic; Forecasting; Gastrointestinal Neoplasms; Hemorrhage; Humans; Immunologic Factors; Lymphocytosis; Lymphoma, Mantle-Cell; Molecular Targeted Therapy; Neoplasm Proteins; Opportunistic Infections; Piperidines; Protein Kinase Inhibitors; Pyrazines; Pyrazoles; Pyrimidines; Salvage Therapy | 2019 |
Pathogenesis and management of bleeding and thrombosis in plasma cell dyscrasias.
Topics: Blood Coagulation Disorders; Blood Platelet Disorders; Boronic Acids; Bortezomib; Hemorrhage; Humans; Immunosuppressive Agents; Paraproteinemias; Protease Inhibitors; Pyrazines; Retrospective Studies; Thalidomide; Thrombosis | 2009 |
6 other study(ies) available for pyrazines and Bleeding
| Article | Year |
|---|---|
Ligustrazine inhibits platelet activation via suppression of the Akt pathway.
Topics: Animals; Calcium; Hemorrhage; Insulin-Like Growth Factor I; Male; Phosphorylation; Platelet Activation; Platelet Aggregation; Proto-Oncogene Proteins c-akt; Pyrazines; Rats, Sprague-Dawley; Signal Transduction; Thromboxane A2 | 2019 |
Generalized cutis laxa and fibrillar glomerulopathy resulting from IgG Deposition in IgG-lambda Monoclonal Gammopathy: pulmonary hemorrhage during stem cell mobilization and complete hematological response with bortezomib and dexamethasone therapy.
Topics: Antineoplastic Agents; Boronic Acids; Bortezomib; Cutis Laxa; Dexamethasone; Granulocyte Colony-Stimulating Factor; Hemorrhage; Humans; Immunoglobulin G; Kidney Diseases; Kidney Glomerulus; Lung; Male; Middle Aged; Paraproteinemias; Pyrazines | 2009 |
Adenovirus-associated hemorrhagic cystitis in a patient with plasma cell myeloma treated with bortezomib.
Topics: Adenovirus Infections, Human; Adenoviruses, Human; Aged; Antineoplastic Agents; Boronic Acids; Bortezomib; Cystitis; Female; Hemorrhage; Humans; Multiple Myeloma; Pyrazines | 2009 |
Bortezomib-related diffuse alveolar hemorrhage.
Topics: Aged; Antineoplastic Agents; Boronic Acids; Bortezomib; Hemorrhage; Humans; Lung Diseases; Male; Multiple Myeloma; Pulmonary Alveoli; Pyrazines | 2012 |
Assessment of bleeding propensity in non-human primates by combination of selective tissue factor/VIIa inhibition and aspirin compared to warfarin and aspirin treatment.
Topics: Aminobenzoates; Animals; Anticoagulants; Aspirin; Bleeding Time; Dose-Response Relationship, Drug; Drug Combinations; Factor VIIa; Hemorrhage; Macaca fascicularis; Male; Platelet Aggregation Inhibitors; Prothrombin Time; Pyrazines; Thromboplastin; Warfarin; Whole Blood Coagulation Time | 2004 |
Neutralization of the haemorrhagic activities of viperine snake venoms and venom metalloproteinases using synthetic peptide inhibitors and chelators.
Topics: Animals; Biphenyl Compounds; Chelating Agents; Chromatography, Gel; Chromatography, Liquid; Edetic Acid; Egtazic Acid; Ethylenediamines; Evaluation Studies as Topic; Hemorrhage; Hydroxamic Acids; Metalloproteases; Mice; Molecular Structure; Organic Chemicals; Phenylbutyrates; Protein Kinase Inhibitors; Pyrazines; Snake Bites; Statistics, Nonparametric; Sulfonamides; Viper Venoms | 2007 |